Asset Details
Do you wish to reserve the book?
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA
Do you wish to request the book?
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Relationship between age and erectile dysfunction diagnosis or treatment using real-world observational data in the USA
2016
Overview
Summary Aims With self‐reporting of erectile dysfunction (ED) in population‐based surveys, men with ED may not represent men who are bothered sufficiently to seek an ED diagnosis and treatment. We used real‐world observational data to assess: 1) the prevalence of ED diagnosis or treatment by age subgroups; and 2) the relationship of age with ED diagnosis or treatment after controlling for ED‐related comorbidities in the USA. Methods This cross‐sectional study used de‐identified claims data (MarketScan® databases; primary analysis). Sensitivity analysis was conducted using electronic health records (Humedica® database). Inclusion criteria were men aged ≥18 years with a 360‐day continuous enrollment before the index date. We assessed the prevalence of ED diagnosis or phosphodiesterase type 5 inhibitor (PDE5I) prescription by age and the risk for ED diagnosis or treatment by age after controlling for comorbidities (hypertension, other cardiovascular disease, diabetes mellitus, depression and benign prostatic hyperplasia). Results Of 19,833,939 men meeting inclusion criteria in the primary analysis, only 1 108 842 (5.6%) had an ED diagnosis or PDE5I prescription (mean [SD] age: 55.2 [11.2] years). Prevalence of ED diagnosis or treatment increased from age 18–29 years (0.4%) to 60–69 years (11.5%), then decreased in the seventh (11.0%), eighth (4.6%), and ninth (0.9%) decades. Men with ED diagnosis or treatment had a higher prevalence of any comorbidity (63.1% vs 29.3% for men without ED) and of each comorbid condition. In multivariate analyses, age was an independent risk factor for ED diagnosis or treatment. Sensitivity analysis provided consistent results. Conclusions In a real‐world setting in the USA, the prevalence of ED diagnosis or PDE5I treatment is generally low, increases with age, decreases in very old men, and is associated with increased prevalence of comorbidities. Age is an independent risk factor for ED diagnosis or treatment after controlling for comorbidities.
Publisher
Blackwell Publishing Ltd,John Wiley & Sons, Inc
Subject
/ Age
/ Aged
/ Cardiovascular Diseases - epidemiology
/ Diabetes
/ Diabetes Mellitus, Type 2 - epidemiology
/ Erectile Dysfunction - diagnosis
/ Erectile Dysfunction - drug therapy
/ Erectile Dysfunction - epidemiology
/ Humans
/ Male
/ Phosphodiesterase 5 Inhibitors - therapeutic use
/ phosphodiesterase type 5 inhibitors
